December 31, 2009 at 10:43 AM EST
Drug benchmarks trade little changed; Pfizer slips
With drug stocks mostly trading in a narrow range, Pfizer draws scrutiny on word that U.S. regulators have yet to take final action on a marketing application Prevnar 13, the company’s new pediatric vaccine.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here